Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biopharma Cred. (BPCR) Share Price

Price $0.938 on 03-03-2026 at 11:51:06
Change $-0.004 -0.42%
Buy $0.946
Sell $0.936
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 8,381.00 at $0.953559
Day's Volume: 915,959
Last Close: $0.942
Open: $0.942
ISIN: GB00BDGKMY29
Day's Range $0.932 - $0.97
52wk Range: $0.80 - $0.972
Market Capitalisation: $1.06b
VWAP: $0.953699
Shares in Issue: 1.13b

Sector: Closed End Investments

Biopharma Cred. (BPCR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 8,381 $0.953559 Currency Conversion
Negotiated Trade
 11:51:04 - 03-Mar-26
Sell* 49 $0.936 SI Trade
 11:41:30 - 03-Mar-26
Sell* 38,105 $0.938 Automatic Execution
 11:40:59 - 03-Mar-26
Buy* 17 $0.946 SI Trade
 11:39:28 - 03-Mar-26
Sell* 750 $0.938 SI Trade
 11:39:28 - 03-Mar-26
Buy* 5 $0.946 SI Trade
 11:39:28 - 03-Mar-26
Buy* 6 $0.946 SI Trade
 11:39:28 - 03-Mar-26
Sell* 145 $0.938 SI Trade
 11:39:28 - 03-Mar-26
Buy* 4 $0.946 SI Trade
 11:39:28 - 03-Mar-26
Buy* 3,888 $0.946 Automatic Execution
 11:39:28 - 03-Mar-26
See more Biopharma Cred. trades

Biopharma Cred. (BPCR) Share Price History

Time period:
to
Date Open High Low Close Volume
3rd Mar 2026 (Tue) 0.942 0.97 0.932 0.942 915,959
2nd Mar 2026 (Mon) 0.95 0.952 0.938 0.942 1,145,561
27th Feb 2026 (Fri) 0.934 0.95 0.934 0.948 932,006
26th Feb 2026 (Thu) 0.94 0.95 0.94 0.948 1,233,855
25th Feb 2026 (Wed) 0.936 0.944 0.936 0.94 953,316
24th Feb 2026 (Tue) 0.94 0.946 0.936 0.936 919,073
23rd Feb 2026 (Mon) 0.948 0.948 0.93 0.94 874,115
20th Feb 2026 (Fri) 0.946 0.946 0.93 0.93 1,156,286
19th Feb 2026 (Thu) 0.96 0.97 0.938 0.942 2,113,373
18th Feb 2026 (Wed) 0.968 0.972 0.966 0.97 855,219
17th Feb 2026 (Tue) 0.962 0.968 0.962 0.968 1,645,764
16th Feb 2026 (Mon) 0.96 0.968 0.96 0.966 7,121,972
13th Feb 2026 (Fri) 0.96 0.964 0.948 0.952 1,396,879
12th Feb 2026 (Thu) 0.94 0.97 0.94 0.968 2,970,714
11th Feb 2026 (Wed) 0.922 0.94 0.92 0.934 3,034,161
10th Feb 2026 (Tue) 0.926 0.926 0.92 0.922 738,566
9th Feb 2026 (Mon) 0.92 0.928 0.92 0.922 582,586
6th Feb 2026 (Fri) 0.92 0.928 0.92 0.926 476,388
5th Feb 2026 (Thu) 0.926 0.928 0.916 0.92 1,289,661
4th Feb 2026 (Wed) 0.926 0.93 0.926 0.93 338,034
3rd Feb 2026 (Tue) 0.922 0.934 0.922 0.93 955,723
See more Biopharma Cred. price history

Biopharma Cred. (BPCR) Regulatory News

Date Source Headline
2nd Mar 2026 1:39 pm RNS UPDATE ON INVESTMENT
20th Feb 2026 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
10th Feb 2026 5:20 pm RNS Dividend Declaration
3rd Feb 2026 7:00 am RNS Notice of Full Year Results
23rd Jan 2026 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
30th Dec 2025 1:32 pm RNS STATEMENT RE COLLEGIUM PREPAYMENT
30th Dec 2025 1:32 pm RNS STATEMENT RE COLLEGIUM PREPAYMENT
19th Dec 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
21st Nov 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
4th Nov 2025 3:29 pm RNS Director/PDMR Shareholding
See more Biopharma Cred. regulatory news

Biopharma Cred. (BPCR) Share News

IN BRIEF: BioPharma Credit receives funds from loan prepayment

30th Dec 2025 19:48

BioPharma Credit PLC - London-based closed-ended investment company focused on life sciences industry - Notes Collegium Pharmaceutical Inc's repayment in full of a USD645.8 million senior secured term loan, in which BioPharma Credit had invested USD290.4 million in July 2024. It receives prepayment proceeds of USD261.4 million of principal with USD2.6 million of prepayment fees and USD5.3 million of accrued interest. BioPharma Credit says its cash balance is now around USD405 million. Read More

UK dividends calendar - next 7 days

24th Oct 2025 11:25

Read More

IN BRIEF: Biopharma Credit increases loan commitment to Valneva

7th Oct 2025 11:22

BioPharma Credit PLC - London-based closed-ended investment company focused on life sciences industry - Provides a senior secured loan to Valneva Austria GmbH, a subsidiary of Valneva SE. Initial tranche is expected to be funded in the coming weeks, with BioPharma investing USD30 million and BioPharma Credit Investments V (Master) LP investing an additional USD185 million in parallel, and BioPharma acting as collateral agent. "Further tranches of up to USD285 million for potential business development are subject to mutual agreement by the parties with loan allocations to be determined at such time," BioPharma adds. The loan to Valneva will mature in October 2030 and bear an interest of 9.00% per year. Read More

BioPharma Credit expects pipeline growth as net asset value ticks up

22nd Sep 2025 09:37

(Alliance News) - BioPharma Credit PLC on Monday said net asset value increased, while the net income for the first half of the year substantially covered its annual dividend target. Read More

UK earnings, trading statements calendar - next 7 days

15th Sep 2025 15:29

Read More

See more Biopharma Cred. news
FTSE 100 Latest
Value10,494.31
Change-285.80

Login to your account

Forgot Password?

Not Registered